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ElectrophysiologyExternal Na+ self-inhibition is an intrinsic feature of epithelial sodium channels (ENaC). Cpt-cAMP regulates
heterologous guinea pig but not ratαβγ ENaC in a ligand-gated manner. We hypothesized that cpt-cAMPmay
eliminate the self-inhibition of human ENaC thereby open channels. Regulation of self-inhibition by this
compound in oocytes was analyzed using the two-electrode voltage clamp and Ussing chamber setups.
External cpt-cAMP stimulated human but not rat and murine αβγ ENaC in a dose- and external Na+
concentration-dependent fashion. Intriguingly, cpt-cAMP activated human δβγ more potently than αβγ
channels, suggesting that structural diversity in ectoloop between human α, δ, and those ENaC of other
species determines the stimulating effects of cpt-cAMP. Cpt-cAMP increased the ratio of stationary and
maximal currents. Mutants having abolished self-inhibition (βΔV348 and γH233R) almost completely
eliminated cpt-cAMP mediated activation of ENaC. On the other hand, mutants both enhancing self-
inhibition and elevating cpt-cAMP sensitivity increased the stimulating effects of the compound. This
compound, however, could not activate already fully opened channels, e.g., degenerin mutation (αβS520Cγ)
and the proteolytically cleaved ENaC by plasmin. Cpt-cAMP activated native ENaC to the same extent as that
for heterologous ENaC in human lung epithelial cells. Our data demonstrate that cpt-cAMP, a broadly used
PKA activator, stimulates human αβγ and δβγ ENaC channels by relieving self-inhibition.Science Center at Tyler 11937
t.
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Epithelial Na+ channels (ENaC) are an apically located critical
pathway for reabsorbing salt from luminal solution [1–3]. ENaC may
serve as a ligand-gated channel and regulated by external compounds
[2,4]. These compounds include para-chloromercuribenzoate [2],
benzimidazoly-2-guanidinium [2], protons [5–7], Cl- [8], multivalent
cations [9,10], cpt-cAMP [11], 8-pCPT-cGMP [12], glibenclamide [13],
gaseous halothane [14], bumetanide [15], and a small molecule S6939
[16]. Among them, some have been reported to abolish external Na+
self-inhibition, an intrinsic phenomenon of ENaC, sensitive to
temperature [2,4,5,9,17–19]. In sharp contrast, Collier and Snyder
proved that extracellular chloride enhances this process and thereby
inhibits ENaC in a pH-dependent manner [8]. In addition to ENaC,
acid-sensing Na+ channels (ASIC), a branch of the ENaC/DEG super
gene family, are gated by external protons [20]; and FaNaC channels
are manipulated by FMRFamide and related tetrapeptides [21].
Cpt-cAMP, as a cell permeable speciﬁc PKA activator has long been
used for studying epithelial Na+ channels. Chraibi and colleaguesfound that the compound speciﬁcally activated guinea pig but not rat
ENaC in oocytes [11]. Furthermore, a key responsive domain in guinea
pig α subunit (Ile481) was identiﬁed [22]. Human ENaC responded to
cpt-cAMP in a dose-dependent, time-independent, and reversible
manner [23]. In addition to these heterologous channels, amiloride-
sensitive, cpt-cAMP activated cation channels were also reported in
human Clara cells (H441) and human lymphocytes in a similar
manner [24–27]. To date, the interpretation for the acute activation of
both native and heterologous human ENaC activity by cpt-cAMP is
still limited to the mediation of PKA pathway.
A number of critical amino acid residues are involved in governing
self-inhibition. Sheng and co-workers identiﬁed that the cysteine and
histidine residues in α and γ subunits were critical [28,29]. Very
recently, this group provided strong evidence that αGly481 and
γMet438 resided in the thumb domain and were functional determi-
nants of self-inhibition [19]. In addition to the relief of self-inhibition,
the external ligand-like compounds activated ENaC channels analog to
serine proteases [30–32]. Our recent observations on the regulation of
ENaC by 8-pCPT-cGMP are supportive to this notion [12].
The aim of this study was to examine if cpt-cAMP relieves self-
inhibition thereby activating human ENaC activity.We observed that this
compound activates ENaC in a dose-dependent manner only when
perfused to cell surface. Abrogationof self-inhibition inmutated channels
eliminated the response to cpt-cAMP while mutations amplifying self-
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not activate already fully opened channels bymutating degenerin site or
protease exposure.
2. Materials and methods
2.1. Site-directed and deletion mutagenesis
Wild type human α, β, γ, and δ ENaC cDNAs were a gift from Dr.
Lingueglia [33]. Single point mutants were generated using the
QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA).
All the mutants were conﬁrmed by sequencing.
2.2. Oocyte expression and voltage clamp studies
Oocytes were surgically removed from appropriately anesthetized
adult female Xenopus laevis (Xenopus Express) and cRNAs for fullFig. 1. Activation of heterologous αβγ ENaC activity by cpt-cAMP. A. Representative current
inhibitable current associated with human αβγ ENaC. Holding potential,−100 mV. B. The ra
Paired t-test, ***Pb0.001. n=6. C. Representative current traces showing the responses to a
Na+ solution, ND1 (1 mM Na+, square). D. Dose-response curves of amiloride-sensitive curr
data with the Hill equation to compute the EC50 values. n=~13. E. Species diversity in resplength and mutated α, β, and γ ENaC were prepared as described
previously [34]. Brieﬂy, the ovarian tissue was removed from frogs
under anesthesia by ethyl 3-aminobenzoate methanesulfonate salt
(Sigma) through a small incision in the lower abdomen. Ovary lobes
were removed and digested in OR-2 calcium-free medium (in mM:
82.5 NaCl, 2.5 KCl, 1.0 MgCl2, 1.0 Na2HPO4, and 10.0 HEPES, pH 7.5)
with the addition of 2 mg/ml collagenase (Roche Indianapolis).
Defolliculated oocytes were cytosolically injected with ENaC cRNAs
(25 ng per oocyte in 50 nl of RNase free water) and incubated in half-
strength L-15 medium at 18 °C. The two-electrode voltage clamp
technique was used to record whole-cell currents 48 h post injection.
Oocytes were impaled with two electrodes ﬁlled with 3 M KCl, having
resistances of 0.5–2 MΩ. A TEV-200 voltage clamp ampliﬁer (Dagan)
was used to clamp oocytes with concomitant recording of currents.
Two reference electrodes were connected to the bath. The continu-
ously perfused bathing solution was ND96 medium (in mM: 96.0
NaCl, 1.0 MgCl2, 1.8 CaCl2, 2.5 KCl, and 5.0 HEPES, pH 7.5). Whole-celltrace showing the effects of microinjected and perfused cpt-cAMP on amiloride (amil)
tio of the current levels recorded after and before cpt-cAMP application (Icpt-cAMP/IBasal).
variety of cpt-cAMP concentrations in oocytes bathed with regular ND96 (circle) or low
ents (ASI). The solid (ND96) and dashed lines (ND1) were created by ﬁtting the current
onse to cpt-cAMP among human, rat, and mouse αβγ ENaCs. n=13. *Pb0.05.
Fig. 2. Divergent responses of human δβγ, αβγ, and δαβγ ENaCs to cpt-cAMP. A–C. Dose response curves of αβγ (A), δβγ (B), and δαβγ ENaC (C). Average amiloride-sensitive
currents (ASI) measured at the cpt-cAMP ranging from 0 to 1 mM were ﬁtted with the Hill equation. n=8–9. *Pb0.05 vs that at 0 mM cpt-cAMP. Paired t-test. D. Current ratio
showing the responses to cpt-cAMP (Icpt-cAMP/IBasal). *Pb0.05 vs αβγ ENaC.
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were controlled by pCLAMP 10.1 software (Molecular Devices), and
currents at −40 mV, −100 mV, and +80 mV were continuously
monitored with data recorded at intervals of 10 s. Data were sampled
at the rate of 1000 Hz and ﬁltered at 500 Hz.Fig. 3. Responses of “loss-of-self-inhibition” mutants to cpt-cAMP. A. Representative current
currents (ASI) at−100 mV in the absence (basal) and presence of cpt-cAMP. *Pb0.05 vs basalTo study the self-inhibition, a low Na+ (1 mM) bath solution was
used (95 mM Na+ in regular ND-96 medium was substituted with
equal molar NMDG). 8-pCPT-cAMP (AXXORA, LLC, San Diego, CA)
stock solution (50 mM) was prepared in water and stored at−20 °C.
MTSET (Toronto Research Chemicals, Downsview, ON, Canada) wastraces of wild type αβγ, αβΔV348γ, and αβγH233R channels. B. Amiloride-sensitive Na+
levels. Paired t-test. n=6–8. C. Current ratio. ***Pb0.001 vsαβγ ENaC. Two-sample t-test.
Fig. 4. Loss of responses to cpt-cAMP in cells expressing “loss-of-self-inhibition”mutants. A. Representative current traces for αβγ, αβΔV348γ, and αβγH233R. Horizontal lines above
the traces indicate the application of cpt-cAMP. B. Alteration of currents by cpt-cAMP. *Pb0.05 vs that in the absence of drug (Icpt-cAMP/IBasal). Dashed line is the basal level. C. Current
ratio of measurements at 30 s (I30s) over peak levels (Imax) post switching of bath solution from ND1 to ND96 medium. **Pb0.01 vs Basal.
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held at −60 mV continuously while the bath solution was switched
quickly between regular ND-96 and the low Na+ solutions, controlled
with an SF-77B Perfusion Fast-Step System (Warner Ins.).Fig. 5. Effects of cpt-cAMP on “gain-of-self-inhibition” mutants. A. Representative self-inh
currents by cpt-cAMP. *Pb0.05 vs αβγ and $Pb0.05 vs Imax.2.3. Human lung epithelial cell culture and Ussing chamber studies
H441 cells (ATCC) were cultured in air-liquid interface as
described previously [36]. Conﬂuent tight monolayers with highibition traces for αβγ, αY458Aβγ, αβγM432G, and αY458AβγM432G. B. Up-regulation of
Fig. 6. Response of cpt-cAMP enhancing mutant (αS483Iβγ). A. Representative self-inhibition traces for αβγ, αS483Iβγ, and αS483IβγM432G. B. Icpt-cAMP/Ibasal ratio. *Pb0.05 vs αβγ.
Numbers in brackets are examined cells.
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vertical Ussing chambers (Physiologic Instrument). To prevent
proteolytic cleavage of ENaC, protease inhibitor cocktail (2 μg/ml,
Roche) was added to culture medium 12 h prior to recording.
Amiloride-sensitive short-circuit currents (ASIsc) were compared
between controls (saline treated) and monolayers preincubated
with protease inhibitors.
2.5. Data analysis
All results were presented as mean±S.E.M. Dose-response curves
were ﬁtted to the Hill equation. Student's t-test or one-way ANOVA
computations were used to analyze the difference of the means for
normally distributed data. Pb0.05 was considered signiﬁcant.
3. Results
3.1. External but not internal cpt-cAMP acutely stimulates human ENaC
in a dose-dependent manner
ENaC channels have been proposed to behave as ligand-gated
cation channels and acutely activated by cpt-cAMP [2,4]. Taking
advantage of the PKA-independent regulation of heterologously
expressed human ENaC in oocytes, we examined the effects of cpt-
cAMP, either external perfusion or intraoocyte microinjection, on
human αβγ ENaC in oocytes. Repeatedly, delivery of three doses
(0.2 mM) of cpt-cAMP into cytosol did not alter the current level
(Fig. 1A). Subsequent superfusion of the drug (0.2 mM), in striking
contrast, to the same cell rapidly evoked the current approximately 2
fold (Fig. 1A and B). Both basal and elevated currents were sensitive to
amiloride. This stimulatory effect of cpt-cAMP depended on external
Na+ content. Substitution of bath Na+ ionswith impermeable cationic
molecule-NMDG markedly eliminated the action of ENaC by the
compound (Fig. 1C). These results suggest that cpt-cAMP signiﬁcantly
stimulates human αβγ ENaC activity only when applied extracellu-
larly. Furthermore, by ﬁtting the experimental data to the Hill
equation (Fig. 1D), an EC50 value of 49.0±14 μM was calculated,with a Hill coefﬁcient constant of 0.6±0.08 (n=5, R2=0.997).
Application of cpt-cAMP more than 2 mM, however, dramatically
reduced ENaC currents (not shown). The concentration–effect
relationship was diminished when oocytes were perfused with the
bath solution containing 1 mMNa+ ions (n=13). Obviously, external
cpt-cAMP activates αβγ ENaC in a dose- and external Na+ content-
dependent manner.
In addition, divergent responses were observed among human, rat,
and mouse ENaCs (Fig. 1E). The same dose (0.2 mM) of cpt-cAMP
caused a signiﬁcant increment in human (82%, Pb0.05 vs basal level)
but not rat (17%) and mouse ENaC activities (15%).3.2. Enhanced responses of human δβγ ENaC to cpt-cAMP
Both α and δ ENaC are detected in human epithelial cells
biochemically and physiologically, including airway, pneumocytes,
and pleural mesothelia [37–39]. Although several stoichiometric
models have been proposed for ENaC channels, including 3α3β3γ,
2α1β1γ, and 1α1β1γ, it appears that the biophysical features of
channels do not depend on the architecture of channels, and that the
crystal structure of ENaC has not been reported to date [40–46].
However, δ ENaC conferred the biophysical properties of αβγ
channels and formed channels with a unitary Na+ conductance of
8 pS, in agreement with that of neither αβγ (4 pS) nor δβγ channels
(12 pS) [37]. To compare the responses of humanαβγ, δβγ, andαβγδ
channels to cpt-cAMP, we examined the concentration dependence
(Fig. 2). Again, cpt-cAMP stimulated human αβγ ENaC in a dose-
dependent manner (Fig. 2A). Intriguingly, δβγ but not δαβγ currents
rose to a relatively greater level at 1 mM (Fig. 2B and C). The EC50
values for δαβγ channels were 30.2±1.2 μM, similar to that of αβγ
(Fig. 2A). The EC50 value for δβγ ENaC, however, cannot be computed
precisely due to unsaturated dose of the compound. The solubility of
sodium salt of cpt-cAMP and a potential increase of external Na+
concentration limited us to apply higher doses to δβγ ENaC. As
predicted by the available experimental data for δβγ ENaC, a dose of
N100 mM is required to obtain the saturated effects of cpt-cAMP.
Although the basal ENaC activity of δαβγ ENaCwas greater than those
Fig. 7. Effects of cpt-cAMP on a degenerin mutant (αβS520Cγ). A. Representative current
trace at −100 mV showing the diverse effects of cpt-cAMP before and after MTSET.
B. Average ENaC currents (ASI). **Pb0.01 vs basal; $$Pb0.001 and $$$Pb0.01,
respectively, vs those in the absence of MTSET. C. Current ratio of cpt-cAMP activated
and basal levels. ***Pb0.001.
Fig. 8. Regulation of proteolytically cleaved ENaC by cpt-cAMP. A. Representative
current trace from an oocyte preincubated with plasmin (10 μg/ml) for 3 h in OR-2
medium. B. Average increase in both Imax and I30s levels. C. Current ratio. n=12.
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measured at 1 mM and the basal level before perfusion of cpt-cAMP
was greatest for δβγ ENaC (Fig. 2D).
3.3. Response to cpt-cAMP of “loss-of-self-inhibition” mutants
We postulated that the “loss-of-self-inhibition” mutants might not
be activated by cpt-cAMP if cpt-cAMP activates ENaC through relieving
self-inhibition. As shown in Fig. 3A and B, the whole-cell Na+ currents
associated with two “loss-of-self-inhibition” mutants (βΔV348 and
γH233R) were not activated by cpt-cAMP in contrast to wild type αβγ
(Fig. 3B and C). Furthermore, we analyzed self-inhibition of βΔV348 and
γH233R channels (Fig. 4). Cpt-cAMP increased the current levels (I30s)
measured 30 s post switching bath solution to ND-96 medium of wild
type but not mutated channels (Fig. 4A and B). The corresponding
current ratio associated with the mutated channels was not increased
compared with wild type channels (Fig. 4C).3.4. Responses of “gain-of-self-inhibition” mutants to cpt-cAMP
In contrast to the “loss-of-self-inhibition” mutants, mutants
reported to enhance self-inhibition might facilitate the up-regulation
of ENaC by cpt-cAMP [19]. To explore this possibility, the increment in
both maximal (Imax) and I30s currents in cells expressing two self-
inhibition boostingmutants, termedαY458A and γM432G, and both, was
examined (Fig. 5A). Above, a 2-fold increase was observed for
mutated channels post cpt-cAMP perfusion for both Imax and I30s
levels (Fig. 5B, Pb0.05).
3.5. Responses of human cpt-cAMP domain mutation (αS483I) to cpt-cAMP
An amino acid residue in the ectoloop of guinea pig α ENaC (I481)
was critical for cpt-cAMP to active ENaC and conferred the response of
rat counterpart [22]. We hypothesized that the substitution of serine
(S483) at the same position in human α counterpart with isoleucine
might augment the stimulatory effect of cpt-cAMP. Indeed, cpt-cAMP
signiﬁcantly evoked both Imax and I30s levels of αS483I (Fig. 6A and B).
Furthermore, we co-expressed this mutant with γM432G, a “gain-of-self-
inhibition”mutant to examine the potential co-ordination in facilitating
the stimulatory effects of cpt-cAMP. Both Imax and I30s levels were
greater than that of αS483I alone (Fig. 6B). These observations indicate
Fig. 9. Relief of self-inhibition by protease inhibitors in human lung epithelial cells (H441 cells). A. Transepithelial short-circuit currents (Isc) showing the effects of cpt-cAMP
(0.5 mM) in monolayers preincubated with protease inhibitor cocktail (right) and controls (left). B. Average amiloride-sensitive (AS) currents in untreated (Control) and cells
pretreated with protease inhibitor cocktail (PIC). n=6–8. *Pb0.05 vs Basal. C. Stimulating potency of cpt-cAMP (Imax/IBasal). n=6–8. *Pb0.05 vs Controls.
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which in turn, favors the stimulation of ENaC by cpt-cAMP.
3.6. Cpt-cAMP does not activate fully opened channels
Both native and heterologously expressed ENaC could be activated by
serine proteases following proteolytic cleavage of ectoloop [30,31,47,48].
There is a pool of uncleaved or partially cleaved channels at the cell
surface that are inhibited by external Na+ ions. Proteases (e.g., trypsin)
increase the channel activity and render them relatively insensitive to
external Na+ signal. This raised a new issue that cpt-cAMPmay regulate
ENaC by increasing channel open time. Thus, the response to cpt-cAMPof
a maximally opened mutant, termed βS520C, was examined before and
after application of MTSET, a thiol modifying reagent used to lock each
channel at its full open state (Fig. 7A). Before addition of MTSET, cpt-
cAMP reversibly increased the current at−100 mV approximately 2 fold
from −1,515±255 to −2,913±561 nA (Fig. 7B, Pb0.01). Subsequent
perfusion ofMTSET increased the basal current to−8555±1370 nA (5.6
fold of basal current, Pb0.001). The same dose of cpt-cAMP did not affect
currents inMTSET-exposed cells (Fig. 7A and B). The cpt-cAMP activated
currents were signiﬁcantly lesser than that in the absence of MTSET
(Fig. 7C, Pb0.001).
Alternatively, we tested the effects of cpt-cAMP on fully opened
channels in cells exposed to protease-plasmin [49–51]. Neither total
currents nor stationary over maximal current ratio was altered by cpt-
cAMP (Fig. 8). Taken together with the results in MTSET pretreated
cells (Fig. 7), cpt-cAMP may eventually lead to an increment in
channel activity via increasing open time.
3.8. Cleavage abolishes cpt-cAMP-mediated ENaC activation in human
lung epithelial cells
To corroborate theﬁndings in oocytes,we evaluated the effects of cpt-
cAMP on native ENaC in human lung epithelial cells (H441monolayers),
in which biochemically and physiologically detectable ENaCs wereevoked by cpt-cAMP [24]. Cpt-cAMP activated amiloride-inhibitable Isc
levels by approximately 8% (Fig. 9A, left panel), which was much lesser
than that for cloned ENaC in oocytes (2 fold). It is possible that ENaC
proteins in carcinoma H441 cells probably have been cleaved by
overexpressed proteases [52,53]. We thus incubated cells with protease
inhibitors for 12 h. As anticipated, cpt-cAMP increased Isc level up to
2-fold in cells pretreated with protease inhibitors (Fig. 9B and C).
4. Discussion
Cyclic AMP and its catalogs, particularly the cell permeable
compounds, are designed to modulate cAMP-PKA signal pathway.
Native ENaC channels were found to be activated by cell permeable
cpt-cAMP in pneumocytes [24,54], endometrium [55], cortical
collecting epithelium [56], and peripheral blood lymphocytes [25].
Heterologous ENaC activity was also augmented by cpt-cAMP in
MDCK and oocytes [23,57,58]. The following evidence provides a
novel mechanism for cpt-cAMP mediated acute activation of both
heterologous and native human ENaC channels. First, external but not
internal cpt-cAMP activates ENaC in seconds in a dose-dependent and
reversible manner. Second, the speciﬁc chlorophenylthio (cpt) groups
are required but not other more speciﬁc PKA activators with more
potency in cell permeability [12]. Third, cpt-cAMP may not recruit
new channel proteins to increase electrically detectable channel
density at cell surface, as the stimulatory effects were also observed in
outside-out patches, a cell-free model without functional machinery
for exocytosis, by our and other groups [12,22]. Fourth, mutations
both enhancing and eliminating self-inhibition affect the effects of
cpt-cAMP on ENaC. Fifth, self-inhibition modifying maneuvers,
including proteolytic cleavage and thiol modiﬁcation, prevent the
cpt-cAMP-mediated activation.
So far, the identiﬁed critical amino acid residues in each subunit,
which either boost (i.e., αY458, γM432) or abolish (i.e., αW493, βΔV348,
γH233) self-inhibition, reside in extracellular ﬁnger, thumb, and palm
domains and are the superﬁcial domains of complexes. The location of
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however, conclude that cpt-cAMP directly modiﬁes these self-inhibition
domains, for the fact that external binding sites for H+ and Cl− ions in
crystallized structure of ENaC/DEG proteins [5,8], which also interrupt
self-inhibition, locate differently. Because the unitary conductance was
not altered by cpt-cAMP, theNa+conduction sites of ENaC seemtonot be
modiﬁed. Self-inhibition appears initiated from external ﬁnger and
thumb domains, palm domains are involved in secondarily conducting
the signal of Na+ concentration. The three-dimensional structural
alteration of palm domains may subsequently result in the process of
inactivation of channel gating. Eventually, channel activity is reduced.
Although we do not know if the self-inhibition modifying reagents
augment the Na+ binding and gating processes, which has not been
understood yet so far, it is conceivable to infer that cpt-cAMP and other
compounds may be capable of down-regulating the transition of Na+
signal and resultant gating kinetics.
Few channel proteins, including cyclic nucleotide-gated channels
(CNG), contain intracellular nucleotide-binding domains (NBD) [59].
It is worthy to note that these NBD domains do not require for speciﬁc
structures of nucleotides, even the parental compounds, e.g., cAMP
and cGMP, can bind to the channel proteins [59]. Requirement of
speciﬁc cpt groups in cAMP analogs to activate ENaC implies that cpt-
cAMP may not dock into an external site with similar three-
dimensional structure to NBD domains. Further studies are required
to identify the docking site for cpt-cAMP and other analogs.
Domains in the extracellular loop in human δ ENaC facilitate
activation of ENaC by cpt-cAMP via unknown mechanisms. These
domains may form a more efﬁcient pocket for cpt-cAMP binding, but
our dose-response data do not support this notion. The estimated EC50
value of δβγ ENaC is apparently much greater than those for αβγ and
δαβγ channels (Fig. 2). Diversities in extracellular loop may also
contribute to the species-dependent responses to cpt-cAMP.
The relief of self-inhibition by cpt-cAMP contributes to the acute
effects, in addition to the well-known cAMP–PKA signal pathway.
Althoughcpt-cAMP isnot a natural endogenous cellular signalmolecule,
and the EC50 values are much greater than that for activating PKA,
without doubt, it can bedelivered into epithelial organs, such as alveolar
spaces, as a potent pharmaceutical maneuver to acutely release
edematous disorders. The clinical relevance, in fact, has been implicated
in the up-regulation of ENaC in autosomal recessive pseudohypoaldos-
teronism type 1 (PHA-1) [25] and edematous lung injury [24].Acknowledgments
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